CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients-Reference-Cited by-同舟云学术

CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients

Published:2020-08-11 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Mendrinou Effrosyni,Mashaly Mohamed Elsayed,Al Okily Amir Mohamed,Mohamed Mohamed Elsayed,Refaie Ayman Fathi,Elsawy Essam Mahmoud,Saleh Hazem Hamed,Sheashaa Hussein,Patrinos George P.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference24 articles.

1. The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children;Abo El Fotoh;Seizure,2016

2. Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase;Aouam;Pharmacogenomics,2015

3. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing;Birdwell;Clin. Pharmacol. Ther.,2015

4. CYP3A5 polymorphisms in renal transplant recipients: Influence on tacrolimus treatment;Chen;Pharmacogenom. Personalized Med.,2018

5. Association of CYP3A5*3 and CYP1A1*2C Polymorphism with development of acute myeloid leukemia in Egyptian patients;El Wahab;Asian Pacific J. Cancer Prevention,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic Effect of Cytochrome P450 Family 3 Subfamily A Member 5 (CYP3A5) Genetic Variants in Tacrolimus Dose Determination in Indian Renal Transplant Patients;ACS Pharmacology & Translational Science;2024-08-13

2. Impact of CYP2D6*2A, CYP2D6*4 and CYP3A5*3 genetic polymorphisms on Bisoprolol peak concentration and clinical response in acute coronary syndrome patients;British Journal of Clinical Pharmacology;2024-06-17

3. Exploring the Knowledge, Attitude, and Practice of Sudanese Medical Doctors Towards Tacrolimus, at Ahmed Gasim Hospital, Kidney Transplant Center Unit, Khartoum, Sudan (2022 – 2023);2024

4. Effect of CYP3A4*22, CYP3A5*3 and POR*28 genetic polymorphisms on calcineurin inhibitors dose requirements in early phase renal transplant patients;Pharmacogenetics and Genomics;2023-12-04

5. The impact of CYP3A4 and CYP3A5 genetic variations on tacrolimus treatment of living‐donor Egyptian kidney transplanted patients;Journal of Clinical Laboratory Analysis;2023-10